A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

Michael E. Stadler,Ulrich Germing,Ko Kliche,Km Josten,R. Kuse,Wolf-Karsten Hofmann,H Schrezenmeier,J. Novotny,O Anders,Hartmut Eimermacher,Walter Verbeek,Hans-Heinrich Kreipe,Hermann Heimpel,C. Aul,A. Ganser

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

2004

Michael E. Stadler
Ulrich Germing
Ko Kliche
Km Josten
R. Kuse
Wolf-Karsten Hofmann
H Schrezenmeier
J. Novotny
O Anders
Hartmut Eimermacher
Walter Verbeek
Hans-Heinrich Kreipe
Hermann Heimpel
C. Aul
A. Ganser

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

Keywords:

Aplastic anemia
Cancer research
Gastroenterology
Globulin
Randomization
Phases of clinical research
Immunotherapy
Hematology
Horse
Myelodysplastic syndromes
Medicine
Internal medicine
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

125

Citations